All you need to get started with ETF selection and analysis. Create your account now →
Help us improve your experience. Please confirm your investor type:
ETF What's Up
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
FTXH ETF · First Trust Nasdaq Pharmaceuticals ETF
The FTXH Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: NASDAQ US Smart Pharmaceuticals Index. The FTXH ETF provides physical exposure, so by buying it you actually own parts of all the 50 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 1:30 PM UTC
LIVE
CLOSED
This fund is part ofUS Health Care1M perf.-3.66%
Last price
$33.63
1M perf.
-2.89%
1M flows
+€3M
AuM
€25M
E/R
0.6%
Rating
ESG Consensus®
FTXH
$33.63
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
FTXH
$33.78
+3.86%
US Health Care
-2.65%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -2.89%  | +3.86% | +22.74%  | +39.72% | +37.82% | -5.21% | +2.60% | +2.60% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/12/2026
$33.78
1D NAV change
-1.99%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
50
Inception date
9/20/2016
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
IHF
1M perf.
-5.62%
E/R
0.38%
FHLC
1M perf.
-3.62%
E/R
0.08%
VHT
1M perf.
-4.77%
E/R
0.09%
IYH
1M perf.
-4.94%
E/R
0.38%
XUHC
1M perf.
-3.65%
E/R
0.12%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +3.86% | +22.74% | +39.72% | +37.82% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
95.63%
Ireland
3.49%
Unavailable
0.35%
Other
0.53%
Sectors
Health Care
98.80%
Unavailable
1.20%
Diversification
Total weight of top 15 holdings out of 50
Top 15 holdings
Data as of January 31, 2026
MERCK & CO INC
JOHNSON&JOHNSON
BRISTOL-MYERS SQUIBB
PFIZER
ABBVIE
CARDINAL HEALTH
LILLY
BIOGEN INC
Create a free account to view top holdings
REGENERON PHARMACEUTICALS
GILEAD SCIENCES
VIATRIS INC
VERTEX PHARMACEUTICALS
AMGEN-T
UTD THERAPEUT
ZOETIS INC
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about FTXH ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
FTXH’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
90.36% of holdings have positive scoring
10.01% of holdings have negative scoring
13.29%
64.21%
12.85%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
NASDAQ US Smart Pharmaceuticals Total Return Index - USD
Index ticker
NQSSPHT Index
Index dividend policy
GTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
First Trust
First Trust ID Card
Number of funds
401
Total AuM
€211.16B
Expense ratio range
0.15% - 13.69%
Average expense ratio
0.7991%
Top 5 funds by First Trust
| AuM | ||
|---|---|---|
RDVY | First Trust NASDAQ Rising Dividend Achievers ETF | €17.19B |
SDVY | First Trust SMID Cap Rising Dividend Achievers ETF | €8.73B |
CIBR | First Trust NASDAQ Cybersecurity ETF | €8.53B |
BUFR | FT Vest Fund of Buffer ETF | €7.48B |
FVD | First Trust Value Line Dividend ETF - USD | €7.16B |
Frequently asked questions about FTXH
What does First Trust Nasdaq Pharmaceuticals ETF, FTXH, invest in?
FTXH is a Passive ETF. This ETF provides exposure to Other US Pharmaceuticals Equities.
Which benchmark or index does FTXH replicate?
FTXH tracks the NASDAQ US Smart Pharmaceuticals Total Return Index - USD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of FTXH?
FTXH carries a total expense ratio (TER) of 0.6%, indicating the annual cost for holding the fund.
When was FTXH launched?
FTXH was introduced to the market on September 20, 2016. It trades on United States
Who is the ETF issuer of FTXH?
First Trust Nasdaq Pharmaceuticals ETF, FTXH, is provided by First Trust. Learn more about First Trust here.
What is the current assets under management (AUM) of FTXH?
FTXH oversees €25M in assets as of March 12, 2026.
How has FTXH performed lately?
Based on data from March 12, 2026, FTXH returned -2.89% over the past month, 3.86% over the last three months and 2.60% year-to-date.
What are the latest inflows or outflows for FTXH?
As of March 12, 2026, FTXH recorded net flows of +€3M over the last month and +€5.9M year-to-date.
Does FTXH distribute dividends?
FTXH follows a distributing dividend policy, meaning it pays out income to investors. As of March 12, 2026, its 12-month trailing yield was 1.37%.
What are the main country or region exposures of FTXH?
As of January 31, 2026, FTXH has significant geographic allocations in USA and Ireland.
In which sector or theme does FTXH invest in?
As of January 31, 2026, FTXH focuses largely on Health Care.
How many securities does FTXH hold and how diversified is it?
As of January 31, 2026, FTXH holds 50 positions in its portfolio, with 71.63% of assets concentrated in its top 15 holdings.
What are the main positions in FTXH?
As of January 31, 2026, FTXH top three holdings include MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB.
What is the base currency of FTXH?
The base currency of FTXH is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
